Document Classification

Section Type: RESULTS

Text: After 2 weeks of treatment, TAK-875 produced marked glucose lowering effects in a 75 g oral glucose tolerance test (OGTT) as evidenced by mean SE intergroup differences in plasma glucose AUC (0-3 h) of -12. 98 1. 48 (p < 0. 0001) and -8. 12 1. 49 mmolh/l (p < 0. 0001), for TAK-875 400 mg vs. placebo and TAK-875 100 mg vs. placebo, respectively, and 2 h plasma glucose [-4. 95 0. 71 (p < 0. 0001) and -3. 21 0. 71 mmol/l (p < 0. 0001), respectively].